会社概要
- 正式社名: Lyrus Life Sciences
- 登録国: India
- 住所: #22, 7th Cross, Jaibharath Nagar, Bangalore
- 従業員数: 250 - 499
説明:
Lyrus Life Sciences is a fast-growing global provider of drug development solutions for prescription and OTC pharmaceutical products in regulated markets. Headquartered in Bengaluru, India, and incorporated in 2016 by C. P. Bothra, a foremost leader in India's pharmaceutical industry with more than 40 years of experience, Lyrus aims to provide value-added products across therapies, with a leadership team bringing more than 300 years of combined industry experience.
事業活動
原薬(API)
製造業者臨床試験受託機関(CRO)
完成医薬品(製剤)
製造業者臨床試験受託機関(CRO)
医薬品開発業務受託機関サービス(CRO)
製造業者臨床試験受託機関(CRO)
ATC分類(解剖治療化学分類)
製造業者臨床試験受託機関(CRO)
先発品原薬
製造業者臨床試験受託機関(CRO)
販売市場
- Northern Europe: Denmark, Estonia, Finland, Iceland, Ireland, Latvia, Lithuania, Norway, Sweden, United Kingdom
- Southern Europe: Albania, Croatia, Greece, Italy, Malta, Portugal, Slovenia, Spain
- Eastern Europe: Bulgaria, Czech Republic, Hungary, Poland, Romania, Slovakia
- Western Europe: Austria, Belgium, France, Germany, Luxembourg, Netherlands
当社の製品・サービス
認証
FDA
GMP
ISO
証明
CPHI Milan 2026
10/2026 – 10/2026
CPHI Milan 2026
評価
(0)
(0)
(0)
(0)
(0)
コメント
フィルター:
並べ替え:
コメントはありません。
評価とコメントを残す